Biotechnology Assets, S.A. (BME:BST)
Spain · Delayed Price · Currency is EUR 0.2180
+0.0010 (0.46%)
Aug 27, 2026, 2:42 PM CET
Biotechnology Assets Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -1.92 | -2.92 | 1.57 | -1.94 | -3.01 |
Depreciation & Amortization | 0.93 | 1 | 1.01 | 1.03 | 1.03 |
Other Amortization | 1.09 | 1.21 | 1.45 | 1.12 | 1 |
Asset Writedown & Restructuring Costs | 0.66 | 0.52 | 0.05 | - | 0.06 |
Other Operating Activities | -0.07 | 0.44 | -3.57 | -0.07 | -0.08 |
Change in Accounts Receivable | -0.48 | -0.46 | -1.02 | 0.37 | 0.06 |
Change in Inventory | -0.01 | - | - | - | 0.02 |
Change in Accounts Payable | -0.24 | 0.16 | 0.06 | -0.52 | -0.76 |
Change in Other Net Operating Assets | 0.03 | -0.03 | 0.47 | - | 0.18 |
Operating Cash Flow | -0.01 | -0.07 | 0.05 | -0.02 | -1.5 |
Operating Cash Flow Growth | - | - | - | - | - |
Investing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | -0 | -0.01 | -0.07 | -0.13 | -0.02 |
Sale (Purchase) of Intangibles | -0.34 | -0.71 | -0.26 | -1.99 | -0.64 |
Investing Cash Flow | -0.34 | -0.72 | -0.33 | -2.12 | -0.66 |
Financing Activities
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Short-Term Debt Issued | - | 0.04 | - | - | 0.07 |
Long-Term Debt Issued | 1.19 | 1.52 | 0.59 | 0.59 | 0.73 |
Total Debt Issued | 1.19 | 1.56 | 0.59 | 0.59 | 0.8 |
Short-Term Debt Repaid | -0.78 | - | -0.13 | -0.22 | - |
Long-Term Debt Repaid | -1.53 | -1.65 | -0.59 | -0.59 | -0.56 |
Total Debt Repaid | -2.31 | -1.65 | -0.72 | -0.81 | -0.56 |
Net Debt Issued (Repaid) | -1.13 | -0.09 | -0.13 | -0.22 | 0.24 |
Issuance of Common Stock | 1.75 | 0.9 | 0.51 | 1.51 | 3.01 |
Repurchase of Common Stock | -0 | -0.12 | -0.08 | -0.08 | -0.01 |
Other Financing Activities | -0.04 | -0.05 | -0.37 | -0.06 | 0.05 |
Financing Cash Flow | 0.58 | 0.64 | -0.06 | 1.15 | 3.28 |
Net Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash Flow | 0.23 | -0.16 | -0.34 | -0.99 | 1.12 |
Free Cash Flow
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -0.02 | -0.09 | -0.02 | -0.14 | -1.52 |
Free Cash Flow Growth | - | - | - | - | - |
Free Cash Flow Margin | -0.44% | -2.43% | -0.56% | -4.90% | -46.29% |
Free Cash Flow Per Share | - | -0.00 | - | -0.00 | -0.03 |
Levered Free Cash Flow | -0.65 | 0.75 | 2.5 | -0.97 | -1.77 |
Unlevered Free Cash Flow | -0.56 | 0.86 | 2.69 | -0.76 | -1.24 |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash Interest Paid | 0.11 | 0.13 | 0.07 | 0.13 | 0.53 |
Cash Income Tax Paid | 0 | - | - | 0.02 | 0.11 |
Change in Working Capital | -0.71 | -0.32 | -0.48 | -0.15 | -0.5 |